bempedoic acid 180mg
Sponsors
Esperion Therapeutics, Inc.
Conditions
Hypercholesterolemia
Phase 2
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg, Ezetimibe 10mg, and Atorvastatin 20 mg Triplet Therapy in Patients With Elevated LDL-C
CompletedNCT03051100
Start: 2017-01-19End: 2017-07-05Updated: 2020-04-03
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180mg When Added to PCSK9 Inhibitor Therapy
CompletedNCT03193047
Start: 2017-04-07End: 2018-02-19Updated: 2020-04-03